Division of Pediatric Oncology, Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Support Care Cancer. 2010 Nov;18(11):1487-90. doi: 10.1007/s00520-010-0926-6. Epub 2010 Jun 18.
Acupuncture is frequently used to manage the side effects associated with cancer therapy. In acupuncture practice, the presence of thrombocytopenia is a relative contraindication to acupuncture use among patients with cancer. However, the safety of acupuncture in patients with cancer treatment-related thrombocytopenia has not been previously investigated.
Medical records of 32 patients receiving acupuncture at an academic medical center with an established acupuncture program during treatment for cancer or during stem cell transplantation were reviewed.
Of 237 acupuncture sessions, 20%, 8%, and 19% of the sessions were administered to patients with severe, moderate, and mild thrombocytopenia, respectively. No bleeding side effects were observed.
This retrospective case series provides descriptive data on the safety of acupuncture using Japanese J-type Seirin needles, with mild manual stimulation administered at 0.5-cun depth in patients with cancer with and without thrombocytopenia. Prospective trials are needed to confirm these initial observations.
针灸常用于治疗癌症治疗相关的副作用。在针灸实践中,血小板减少症的存在是癌症患者针灸使用的相对禁忌症。然而,癌症治疗相关血小板减少症患者进行针灸的安全性尚未得到研究。
对在学术医疗中心接受针灸治疗的 32 名癌症患者或干细胞移植期间接受针灸治疗的患者的病历进行了回顾。
在 237 次针灸治疗中,分别有 20%、8%和 19%的治疗分别用于严重、中度和轻度血小板减少症患者。未观察到出血副作用。
本回顾性病例系列提供了关于使用日本 J 型 Seirin 针进行针灸的安全性的描述性数据,在伴有或不伴有血小板减少症的癌症患者中,以 0.5 寸深度进行轻度手动刺激。需要进行前瞻性试验来证实这些初步观察结果。